UBE2E1 and hepatocellular carcinoma: To address the prediction problem, we established a prognostic signature of LINC01136, RP11.298O21.2, RP11.20J15.2, LINC00501, UBE2E1.AS1, LINC01060, and RP5.828H9.1 in HCC and plotted a nomogram to assess patient prognosis.